Neurogene, Inc. (NGNE)
Neurogene Market Cap : 502.85M for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 495.20M |
| November 12, 2026 | 494.58M |
| November 11, 2026 | 519.41M |
| November 10, 2026 | 523.13M |
| November 09, 2026 | 538.03M |
| November 06, 2026 | 523.76M |
| November 05, 2026 | 530.79M |
| November 04, 2026 | 436.61M |
| November 03, 2026 | 422.20M |
| November 02, 2026 | 421.25M |
| October 30, 2026 | 436.13M |
| October 29, 2026 | 456.24M |
| October 28, 2026 | 481.56M |
| October 27, 2026 | 427.27M |
| October 26, 2026 | 372.65M |
| October 23, 2026 | 372.81M |
| October 22, 2026 | 384.36M |
| October 21, 2026 | 412.86M |
| October 20, 2026 | 402.09M |
| October 19, 2026 | 382.62M |
| October 16, 2026 | 368.06M |
| October 15, 2026 | 379.14M |
| October 14, 2026 | 351.12M |
| October 13, 2026 | 341.31M |
| October 12, 2026 | 386.90M |
| Date | Value |
|---|---|
| October 09, 2026 | 417.93M |
| October 08, 2026 | 419.51M |
| October 07, 2026 | 409.54M |
| October 06, 2026 | 402.89M |
| October 05, 2026 | 419.03M |
| October 02, 2026 | 406.05M |
| October 01, 2026 | 420.30M |
| September 30, 2026 | 440.40M |
| September 29, 2026 | 449.43M |
| September 28, 2026 | 450.85M |
| September 25, 2026 | 448.16M |
| September 24, 2026 | 494.70M |
| September 23, 2026 | 489.64M |
| September 22, 2026 | 531.90M |
| September 21, 2026 | 515.60M |
| September 18, 2026 | 508.00M |
| September 17, 2026 | 513.07M |
| September 16, 2026 | 548.84M |
| September 15, 2026 | 533.33M |
| September 14, 2026 | 557.39M |
| September 11, 2026 | 561.67M |
| September 10, 2026 | 571.80M |
| September 09, 2026 | 599.66M |
| September 08, 2026 | 603.62M |
| September 04, 2026 | 611.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.297B |
| Alnylam Pharmaceuticals, Inc. | 21.59B |
| Anika Therapeutics, Inc. | 175.06M |
| Savara, Inc. | 935.19M |
| Arrowhead Pharmaceuticals, Inc. | 6.472B |
Market Cap Related Metrics
| PEG Ratio | -0.1707 |
| Price to Book Value | 1.417 |
| Price | 24.30 |
| Earnings Yield | -22.88% |
| PEGY Ratio | -0.1707 |